NEWARK, DE / ACCESSWIRE / March 2, 2023 / Global medical loupes market size is predicted to reach US$ 588.9 million in 2033 with a projected CAGR of 5.6% during the forecast period. The rise in minimally invasive surgeries has driven the demand for medical loupes. As the aging population increases and the prevalence of chronic diseases rises, there is an increase in surgeries and procedures that require enhanced visualization and precision, which medical loupes provide. Flip-up and TTL medical loupes are some of the latest products gaining popularity in the market. Manufacturers are leveraging advanced materials and technologies to drive the growth of the market. The growth of the medical loupes industry is being driven by the increase in demand for minimally invasive surgeries. Request a sample report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11128 Medical loupes provide surgeons with the necessary magnification and clarity to perform such procedures with ease, which can reduce the risk of errors and complications during surgeries, leading to better patient outcomes.

https://www.investing.com/news/pro/carl-zeiss-meditec-ag-pt-raised-to-eur175-at-deutsche-bank-432SI-3013388

EQS-News: Carl Zeiss Meditec AG / Key word: Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain… | February 10, 2023

Major players in the ophthalmic medical lasers market are Alcon Laboratories Inc, Abbott Medical Optics Inc, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co Ltd, Lumenis Ltd, and Johnson & Johnson. Major players in the ophthalmic medical lasers market are Alcon Laboratories Inc, Abbott Medical Optics Inc, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co Ltd, Lumenis Ltd, and Johnson & Johnson.

https://www.investing.com/news/pro/berenberg-downgrades-carl-zeiss-meditec-ag-to-hold-432SI-2995758